To Determine Bioequivalence Under Fasting Conditions Completed Phase 1 Trials for Dronabinol (DB00470)

IndicationStatusPhase
DBCOND0039998 (To Determine Bioequivalence Under Fasting Conditions)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01380457Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions